Novel Therapies in Primary Central Nervous System Lymphoma
Michel Wakim,1,* Mariana Mezher,2,* Ariel Perez-Perez,3 Arun Maharaj,3 Yazmin Odia,3 Manmeet S Ahluwalia,1,3 Yuliya Linhares1,3 1Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA; 2Faculty of Medical Sciences, Lebanese University, Beirut,...
Saved in:
Main Authors: | Wakim M, Mezher M, Perez-Perez A, Maharaj A, Odia Y, Ahluwalia MS, Linhares Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-05-01
|
Series: | Clinical Pharmacology: Advances and Applications |
Subjects: | |
Online Access: | https://www.dovepress.com/novel-therapies-in-primary-central-nervous-system-lymphoma-peer-reviewed-fulltext-article-CPAA |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case Report: CAR-T therapy for primary cerebellar ALK-negative anaplastic large cell lymphoma
by: Zhongqing Zou, et al.
Published: (2025-07-01) -
Immunomodulating effects of antitumor drugs Bruton tyrosine kinase inhibitors and the possibility of their use in allergic and infectious diseases
by: Yu. S. Torshina, et al.
Published: (2023-06-01) -
Primary Central Nervous System Lymphoma in an Immunocompetent Young Adult Patient: A Rare Case
by: Aisyah Wirdah, et al.
Published: (2023-03-01) -
Case Report: Immune checkpoint inhibitor exhibits dual benefits for a refractory lymphoma patient with disseminated mucormycosis
by: Qibei Teng, et al.
Published: (2025-07-01) -
Treatment of primary central nervous system lymphomas
by: I. V. Cherkashina, et al.
Published: (2021-06-01)